Anti-CD20 antibody compositions
US11807689B1 · kind B1 · utility
0Cited by
19References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 22, 2022 |
| Grant date | Nov 7, 2023 |
| Priority date | — |
| Expiry date | Aug 22, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/734
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are populations of anti-CD20 antibody proteins with specified ranges of post-translational modifications. Also provided are methods of using and methods of making such populations of anti-CD20 antibody proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.